Silvy Laporte

10.9k total citations · 2 hit papers
144 papers, 5.3k citations indexed

About

Silvy Laporte is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Silvy Laporte has authored 144 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Internal Medicine, 68 papers in Cardiology and Cardiovascular Medicine and 38 papers in Surgery. Recurrent topics in Silvy Laporte's work include Venous Thromboembolism Diagnosis and Management (80 papers), Atrial Fibrillation Management and Outcomes (49 papers) and Central Venous Catheters and Hemodialysis (18 papers). Silvy Laporte is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (80 papers), Atrial Fibrillation Management and Outcomes (49 papers) and Central Venous Catheters and Hemodialysis (18 papers). Silvy Laporte collaborates with scholars based in France, United States and Spain. Silvy Laporte's co-authors include Patrick Mismetti, Hervé Decousus, Patrick Mismetti, Philippe Girard, Alain Leizorovicz, H Decousus, Gérald Simonneau, Bernard Tardy, Florence Parent and Yves Page and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Oncology.

In The Last Decade

Silvy Laporte

136 papers receiving 5.1k citations

Hit Papers

A Clinical Trial of Vena Caval Filters in the Prevention ... 1998 2026 2007 2016 1998 2008 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
    1998 1.2k citations Hervé Decousus, Florence Parent et al. New England Journal of Medicine profile →
  2. Clinical Predictors for Fatal Pulmonary Embolism in 15 520 Patients With Venous Thromboembolism
    2008 469 citations Silvy Laporte, Patrick Mismetti et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvy Laporte France 33 3.7k 2.6k 1.7k 1.1k 609 144 5.3k
Hervé Decousus France 33 5.6k 1.5× 3.9k 1.5× 2.1k 1.2× 1.5k 1.3× 350 0.6× 108 6.7k
Patrick Mismetti France 31 5.2k 1.4× 4.6k 1.7× 1.8k 1.0× 692 0.6× 403 0.7× 118 6.8k
Marco Moia Italy 37 3.4k 0.9× 2.8k 1.0× 1.4k 0.8× 806 0.7× 548 0.9× 101 5.9k
Patrick Mismetti France 33 2.9k 0.8× 2.2k 0.8× 1.0k 0.6× 843 0.7× 328 0.5× 154 4.2k
Dominique Mottier France 33 3.5k 0.9× 2.8k 1.0× 1.3k 0.8× 483 0.4× 395 0.6× 143 5.5k
Saurav Chatterjee United States 38 1.6k 0.4× 3.0k 1.1× 956 0.6× 301 0.3× 516 0.8× 153 4.9k
Pieter W. Kamphuisen Netherlands 57 6.5k 1.7× 5.4k 2.0× 1.9k 1.1× 1.2k 1.1× 899 1.5× 230 10.9k
Alessandro Squizzato Italy 42 2.5k 0.7× 2.1k 0.8× 1.2k 0.7× 327 0.3× 604 1.0× 184 5.7k
Barbara A. Hutten Netherlands 51 1.9k 0.5× 3.9k 1.5× 5.3k 3.1× 459 0.4× 566 0.9× 215 10.3k
Sylvia Haas Germany 43 6.4k 1.7× 7.2k 2.7× 1.8k 1.1× 537 0.5× 520 0.9× 209 9.1k

Countries citing papers authored by Silvy Laporte

Since Specialization
Citations

This map shows the geographic impact of Silvy Laporte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvy Laporte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvy Laporte more than expected).

Fields of papers citing papers by Silvy Laporte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvy Laporte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvy Laporte. The network helps show where Silvy Laporte may publish in the future.

Co-authorship network of co-authors of Silvy Laporte

This figure shows the co-authorship network connecting the top 25 collaborators of Silvy Laporte. A scholar is included among the top collaborators of Silvy Laporte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvy Laporte. Silvy Laporte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahé, Isabelle, Didier Mayeur, Françis Couturaud, et al.. (2024). Traduction et republication de : « Traitement anticoagulant de la maladie veineuse thromboembolique associée au cancer ». La Revue de Médecine Interne. 45(4). 210–225. 2 indexed citations
2.
Poénou, Géraldine, et al.. (2024). Latest advances in the reversal strategies for direct oral anticoagulants. Fundamental and Clinical Pharmacology. 38(4). 674–684. 2 indexed citations
3.
Giai, Joris, Silvy Laporte, Édouard Ollier, et al.. (2024). Priors and decision thresholds in phase 2 and phase 3 randomized controlled trials evaluating drug efficacy using Bayesian methods: a systematic review. Journal of Clinical Epidemiology. 179. 111651–111651. 1 indexed citations
4.
Mahé, Isabelle, Didier Mayeur, Françis Couturaud, et al.. (2023). Anticoagulant treatment of cancer-associated thromboembolism. Archives of cardiovascular diseases. 117(1). 29–44. 8 indexed citations
5.
Roustit, Matthieu, Silvy Laporte, Philippe Barthélémy, et al.. (2022). Les essais plateformes. Therapies. 78(1). 19–28. 3 indexed citations
6.
Roustit, Matthieu, Silvy Laporte, Philippe Barthélémy, et al.. (2022). Platform trials. Therapies. 78(1). 29–38. 13 indexed citations
7.
Guedeney, Paul, Sabato Sorrentino, Gennaro Giustino, et al.. (2020). Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysis. European Heart Journal - Cardiovascular Pharmacotherapy. 7(3). 225–235. 44 indexed citations
8.
Mahé, Isabelle, Céline Chapelle, Silvy Laporte, et al.. (2020). Long-Term Treatment of Cancer-Associated Thrombosis (CAT) Beyond 6 Months in the Medical Practice: USCAT, a 432-Patient Retrospective Non-Interventional Study. Cancers. 12(8). 2256–2256. 18 indexed citations
9.
Muriel, Alfonso, David Jiménez, Drahomir Aujesky, et al.. (2014). Survival Effects of Inferior Vena Cava Filter in Patients With Acute Symptomatic Venous Thromboembolism and a Significant Bleeding Risk. Journal of the American College of Cardiology. 63(16). 1675–1683. 131 indexed citations
10.
Lega, Jean‐Christophe, et al.. (2013). Consistency of safety profile of new oral anticoagulants in patients with renal failure. Journal of Thrombosis and Haemostasis. 12(3). 337–343. 28 indexed citations
11.
Gouin‐Thibault, Isabelle, Patrick Mismetti, Claire Flaujac, et al.. (2011). Nouveaux anticoagulants par voie orale : quelle place pour les analyses de biologie médicale ?. Sang thrombose vaisseaux. 23(1). 8–17. 5 indexed citations
12.
Laporte, Silvy, J. Liotier, Laurent Bertoletti, et al.. (2011). Individual patient data meta‐analysis of enoxaparin vs. unfractionated heparin for venous thromboembolism prevention in medical patients. Journal of Thrombosis and Haemostasis. 9(3). 464–472. 30 indexed citations
13.
Mismetti, Patrick & Silvy Laporte. (2010). New oral antithrombotics: a need for laboratory monitoring. For. Journal of Thrombosis and Haemostasis. 8(4). 621–626. 65 indexed citations
14.
Prandoni, P., Patrick Mismetti, Rupert Bauersachs, et al.. (2010). Fondaparinux for the Treatment of Superficial-Vein Thrombosis in the Legs. New England Journal of Medicine. 363(13). 1222–1232. 195 indexed citations
15.
Maillard, Nicolas, Christophe Mariat, Lise Thibaudin, et al.. (2008). Cystatin C-based Equations in Renal Transplantation. Transplantation. 85(12). 1855–1858. 41 indexed citations
16.
Mismetti, Patrick, et al.. (2007). Abstract. Journal of Thrombosis and Haemostasis. 5. SYM–S1. 1 indexed citations
17.
Mismetti, Patrick, Silvy Laporte, & Michel Cucherat. (2007). Les essais de non-infériorité. 13(4). 304–310. 1 indexed citations
18.
19.
Laporte, Silvy & Michel Cucherat. (2006). Multiplicité des tests statistiques au cours d’un essai clinique Plus on cherche, plus on trouve…. 12(3). 183–188. 1 indexed citations
20.
Girard, Philippe, M. Décousus, Silvy Laporte, et al.. (2001). Diagnosis of Pulmonary Embolism in Patients with Proximal Deep Vein Thrombosis. American Journal of Respiratory and Critical Care Medicine. 164(6). 1033–1037. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hervé Decousus Breakdown of academic impact, for papers by Patrick Mismetti Breakdown of academic impact, for papers by Marco Moia Breakdown of academic impact, for papers by Patrick Mismetti Breakdown of academic impact, for papers by Dominique Mottier Breakdown of academic impact, for papers by Saurav Chatterjee Breakdown of academic impact, for papers by Pieter W. Kamphuisen Breakdown of academic impact, for papers by Alessandro Squizzato Breakdown of academic impact, for papers by Barbara A. Hutten Breakdown of academic impact, for papers by Sylvia Haas
Rankless by CCL
2026